<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03311906</url>
  </required_header>
  <id_info>
    <org_study_id>FPGRP/43631003/73</org_study_id>
    <nct_id>NCT03311906</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of 0.8% Hyaluronic Acid Gel</brief_title>
  <official_title>Clinical and Laboratory Effect of 0.8% Hyaluronic Acid Gel in Conventional Treatment of Moderate to Severe Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riyadh Colleges of Dentistry and Pharmacy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riyadh Colleges of Dentistry and Pharmacy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      assess the clinical and laboratory effects of the local and sub gingival application of a
      0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in
      chronic moderate to severe periodontitis patients as indicated by expression of Human Beta
      Definsin-2 (HBD2) in gingival crevicular fluid (GCF).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who fulfilled the selection criteria will be included in the study. One quadrant
      will be treated with HA gel (test) and the other without to serve as control. Clinical
      examination will be done in a dental chair under standard conditions of light, using mouth
      mirror and graduated Williams Periodontal Probe.

      All patients will receive full mouth scaling and root planing with hand instruments and
      ultrasonic scalers at baseline. Thereafter, in the test quadrant, 1 ml of 0.8% hyaluronic
      acid gel will be administered subgingivally in all selected test sites at baseline and 1 week
      later. The following clinical parameters will be recorded at baseline, after 6 weeks and 12
      weeks post treatment. Oral hygiene instructions will be given to all patients. The clinical
      measurements and treatment will be performed by a single examiner.For every patient and
      control subject, GCF samples will be collected at baseline, 6 weeks and 12 weeks post
      treatment. The samples will be pooled from two periodontal sites with clinical attachment
      level of 3 mm or more (in the two different quadrants). The sampling area will be isolated
      with cotton rolls and carefully will be cleaned supragingivally with sterile cotton pellets.
      A sterile absorbent paper point will be inserted into the gingival crevice or pocket until
      resistance will be felt. The paper point will be held in place for 30 s and then will be
      transferred to a vial containing 100 μL of distilled water and vigorously will be mixed. The
      paper points will be removed, and the samples will be centrifuged and will be washed twice
      with distilled water. The resultant pellets will be resuspended in 0.4 mL of distilled water.
      The samples will be coded and stored at −70 °C until use for ELISA test for identification of
      Human beta Defensin-2.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2017</start_date>
  <completion_date type="Actual">October 2, 2017</completion_date>
  <primary_completion_date type="Actual">August 15, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A split mouth study design is used where all participants receive both interventions</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Attachment Level (CAL) change</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>Distance from the cementoenamel junction to the base of gingival sulcus using a UNC15 probe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing Depth change</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>It's the distance from the gingival margin to base of the sulcus</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gingival Index change (Loe and Silness, 1963)</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>To assess the gingival condition and record qualitative chances in the gingiva</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plaque index change (Loe and Silness, 1964)</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>To measure the state of oral hygiene</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Papillary Bleeding Index change (Muhlemann, 1977)</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>immediate evaluation of the patient's gingival motivation and condition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HBD-2 change</measure>
    <time_frame>baseline, six weeks, 12 weeks</time_frame>
    <description>By take gingival crevicular fluid sample elisa test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Test side</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scaling and Root Planing 0.8% Hyaluronic acid gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Side</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and Root Planing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.8% Hyaluronic Acid</intervention_name>
    <description>Application of 0.8% hyaluronic acid after scaling and root planing</description>
    <arm_group_label>Test side</arm_group_label>
    <other_name>Gengigel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and Root Planing</intervention_name>
    <description>Scaling of the teeth using hand and ultrasonic scalers followed by planing of the root with curettes</description>
    <arm_group_label>Test side</arm_group_label>
    <arm_group_label>Control Side</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients should be systemically healthy with moderate to severe chronic periodontitis
             of more than 4 mm probing depth in at least two sites in different quadrants.

          -  Patient should exhibit no known allergies

          -  Participants should have the ability to attend the hospital regular intervals.

        Exclusion Criteria:

          -  pregnancy

          -  nursing

          -  hypertension

          -  patient with chronic diseases such as diabetes mellitus or rheumatoid arthritis.
             -Participants should not be under antibiotics and\or had receive any periodontal
             therapy for the last 6 months.

          -  Participants should not taking drugs that could affect the state of the gingival
             tissues.

          -  Participants must not be undergoing orthodontic therapy, caries free

          -  Participants must not be using any other supplemental plaque control measures like
             mouthwashes.

          -  Participants should not have the habit of taking alcohol, smoking or chewing tobacco
             and do not suffer from any systemic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanaa M Shafshak, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Riyadh Colleges of Dentistry and Pharmacy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riyadh Colleges of Dentistry and Pharmacy</name>
      <address>
        <city>Riyadh</city>
        <state>AlRiyadh</state>
        <zip>11681</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <results_reference>
    <citation>Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005 Mar;3(3):238-50. Review.</citation>
    <PMID>15703760</PMID>
  </results_reference>
  <results_reference>
    <citation>Diamond DL, Kimball JR, Krisanaprakornkit S, Ganz T, Dale BA. Detection of beta-defensins secreted by human oral epithelial cells. J Immunol Methods. 2001 Oct 1;256(1-2):65-76.</citation>
    <PMID>11516756</PMID>
  </results_reference>
  <results_reference>
    <citation>Embery G, Waddington RJ, Hall RC, Last KS. Connective tissue elements as diagnostic aids in periodontology. Periodontol 2000. 2000 Oct;24:193-214. Review.</citation>
    <PMID>11276867</PMID>
  </results_reference>
  <results_reference>
    <citation>García JR, Jaumann F, Schulz S, Krause A, Rodríguez-Jiménez J, Forssmann U, Adermann K, Klüver E, Vogelmeier C, Becker D, Hedrich R, Forssmann WG, Bals R. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001 Nov;306(2):257-64.</citation>
    <PMID>11702237</PMID>
  </results_reference>
  <results_reference>
    <citation>Gontiya G, Galgali SR. Effect of hyaluronan on periodontitis: A clinical and histological study. J Indian Soc Periodontol. 2012 Apr;16(2):184-92. doi: 10.4103/0972-124X.99260.</citation>
    <PMID>23055583</PMID>
  </results_reference>
  <results_reference>
    <citation>Gorr SU. Antimicrobial peptides in periodontal innate defense. Front Oral Biol. 2012;15:84-98. doi: 10.1159/000329673. Epub 2011 Nov 11. Review.</citation>
    <PMID>22142958</PMID>
  </results_reference>
  <results_reference>
    <citation>Gorr SU, Abdolhosseini M. Antimicrobial peptides and periodontal disease. J Clin Periodontol. 2011 Mar;38 Suppl 11:126-41. doi: 10.1111/j.1600-051X.2010.01664.x. Review.</citation>
    <PMID>21323710</PMID>
  </results_reference>
  <results_reference>
    <citation>Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000. 1994 Jun;5:78-111. Review.</citation>
    <PMID>9673164</PMID>
  </results_reference>
  <results_reference>
    <citation>Heitz-Mayfield LJ. How effective is surgical therapy compared with nonsurgical debridement? Periodontol 2000. 2005;37:72-87.</citation>
    <PMID>15655026</PMID>
  </results_reference>
  <results_reference>
    <citation>Jentsch H, Pomowski R, Kundt G, Göcke R. Treatment of gingivitis with hyaluronan. J Clin Periodontol. 2003 Feb;30(2):159-64.</citation>
    <PMID>12622859</PMID>
  </results_reference>
  <results_reference>
    <citation>Johannsen A, Tellefsen M, Wikesjö U, Johannsen G. Local delivery of hyaluronan as an adjunct to scaling and root planing in the treatment of chronic periodontitis. J Periodontol. 2009 Sep;80(9):1493-7. doi: 10.1902/jop.2009.090128.</citation>
    <PMID>19722800</PMID>
  </results_reference>
  <results_reference>
    <citation>Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967 Nov-Dec;38(6):Suppl:610-6.</citation>
    <PMID>5237684</PMID>
  </results_reference>
  <results_reference>
    <citation>LOE H, SILNESS J. PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963 Dec;21:533-51.</citation>
    <PMID>14121956</PMID>
  </results_reference>
  <results_reference>
    <citation>Moseley R, Waddington RJ, Embery G. Hyaluronan and its potential role in periodontal healing. Dent Update. 2002 Apr;29(3):144-8.</citation>
    <PMID>11989392</PMID>
  </results_reference>
  <results_reference>
    <citation>Mühlemann HR. Psychological and chemical mediators of gingival health. J Prev Dent. 1977 Jul-Aug;4(4):6-17.</citation>
    <PMID>275483</PMID>
  </results_reference>
  <results_reference>
    <citation>Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007 Mar;127(3):594-604. Epub 2006 Oct 19.</citation>
    <PMID>17068477</PMID>
  </results_reference>
  <results_reference>
    <citation>Pereira AL, Franco GC, Cortelli SC, Aquino DR, Costa FO, Raslan SA, Cortelli JR. Influence of periodontal status and periodontopathogens on levels of oral human β-defensin-2 in saliva. J Periodontol. 2013 Oct;84(10):1445-53. doi: 10.1902/jop.2012.120321. Epub 2012 Nov 23.</citation>
    <PMID>23173827</PMID>
  </results_reference>
  <results_reference>
    <citation>Pilloni A, Annibali S, Dominici F, Di Paolo C, Papa M, Cassini MA, Polimeni A. Evaluation of the efficacy of an hyaluronic acid-based biogel on periodontal clinical parameters. A randomized-controlled clinical pilot study. Ann Stomatol (Roma). 2011 Mar;2(3-4):3-9. Epub 2012 Jan 27.</citation>
    <PMID>22545183</PMID>
  </results_reference>
  <results_reference>
    <citation>Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW. Bacteriostatic effects of hyaluronic acid. J Periodontol. 1999 Apr;70(4):370-4.</citation>
    <PMID>10328647</PMID>
  </results_reference>
  <results_reference>
    <citation>Polepalle T, Srinivas M, Swamy N, Aluru S, Chakrapani S, Chowdary BA. Local delivery of hyaluronan 0.8% as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A clinical and microbiological study. J Indian Soc Periodontol. 2015 Jan-Feb;19(1):37-42. doi: 10.4103/0972-124X.145807.</citation>
    <PMID>25810591</PMID>
  </results_reference>
  <results_reference>
    <citation>Porter EM, Liu L, Oren A, Anton PA, Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun. 1997 Jun;65(6):2389-95.</citation>
    <PMID>9169779</PMID>
  </results_reference>
  <results_reference>
    <citation>Xu Y, Höfling K, Fimmers R, Frentzen M, Jervøe-Storm PM. Clinical and microbiological effects of topical subgingival application of hyaluronic acid gel adjunctive to scaling and root planing in the treatment of chronic periodontitis. J Periodontol. 2004 Aug;75(8):1114-8.</citation>
    <PMID>15455740</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Riyadh Colleges of Dentistry and Pharmacy</investigator_affiliation>
    <investigator_full_name>Nour Al Shammari</investigator_full_name>
    <investigator_title>Senior Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

